Migraine
📧 Sign up to get email alerts when something new happens for Migraine.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Basic Body Awareness Therapy in Individuals With Migraine [NA]
Sponsored by Mustafa Kemal University, this clinical trial evaluates Basic Body Awareness Therapy for migraine and is NOT_YET_RECRUITING.
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: The Prevalence of Osmophobia in Migraine and Tension-Type Headache Patients and Its Association With Migraine Symptoms Over a Period of 6 Months
A completed clinical trial update assessing the prevalence of osmophobia in patients with migraine and tension-type headaches and its associ…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy
Clinical trial update on pregnancy outcomes in women exposed to rimegepant during pregnancy; the study is currently active but not recruitin…
-
CLINICAL_TRIALS trial_result · 2026-01-05Clinical Trial Update: Effectivity and Safety of GB20 Acupoint Pharmacopuncture With Lidocaine 2% on Migraine Patients [NA]
This trial evaluated the effectiveness and safety of GB20 acupoint pharmacopuncture with lidocaine 2% in migraine patients.
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: Combined Effects of Green Light and Transcranial Direct Current Stimulation in Migraine Patients. [NA]
A clinical trial is exploring the combined effects of green light exposure and transcranial direct current stimulation for migraine, and it …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Rimegepant as Preemptive Treatment for Predictable Trigger-Induced Migraine in Adult Patients in the US [Phase 4]
A Phase 4 clinical trial is evaluating rimegepant as a preemptive treatment for predictable trigger-induced migraines in adults in the Unite…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Efficacy and Safety of Erenumab in Pediatric Participants With Episodic Migraine [Phase 3]
Phase 3 trial evaluating erenumab for episodic migraine in pediatric participants. The study is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: App-based Breathing Program for Migraine Relief [NA]
A clinical trial is evaluating an app-based breathing program for migraine relief and is currently enrolling by invitation.
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Participants 6 to 17 Years of Age [Phase 3]
A Phase 3 pediatric trial evaluating fremanezumab for preventing chronic migraine in participants aged 6 to 17 has completed and posted resu…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Assessment of the Impact of Headache on the Employee Population of Libbs Pharmaceutical Ltd
A sponsored observational study by Libbs Farmacêutica LTDA assessing the impact of headache on its employee population; enrollment is by inv…
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: A Long-Term Safety and Tolerability Extension Study Evaluating Atogepant for the Prevention of Chronic or Episodic Migraine [Phase 3]
Long-term safety and tolerability data from a Phase 3 extension study of atogepant for the prevention of episodic and chronic migraine have …
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: The Impact of Acupuncture on Biomarkers of Brain Injury and Inflammatory Response in Migraine [NA]
This clinical trial update describes a study evaluating whether acupuncture affects biomarkers of brain injury and inflammatory response in …
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens [Phase 4]
Phase 4 trial results update assessing efficacy and safety of rimegepant for the prevention of episodic migraine across multiple dosing regi…
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: AI Chatbot for Migraine Management in Hong Kong Women [NA]
A completed clinical trial conducted by The Hong Kong Polytechnic University evaluated an AI chatbot to aid migraine management in Hong Kong…
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: Observational Study to Assess Adverse Events When Adult Female Participants Are Treated With Ubrelvy (Ubrogepant) or Qulipta (Atogepant) During Pregnancy
Observational study assessing adverse events in adult women treated with Ubrelvy (ubrogepant) or Qulipta (atogepant) during pregnancy.
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: Chronic Pain in the General Population of Chile
This is a completed clinical trial in Chile examining chronic pain and related conditions, including migraine disability and several comorbi…
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: Intra-Nasal Mechanical Stimulation (INMEST) as a Potential Preventative Treatment for Migraine [NA]
This clinical trial update shows ongoing recruitment for intra-nasal mechanical stimulation (INMEST) as a potential preventive treatment for…
-
EMA approval · 2025-12-10EMA Authorised: Aimovig (erenumab) — Novartis Europharm Limited
EMA authorised Aimovig (erenumab) for migraine disorders. Novartis Europharm Limited is listed as the marketing authorisation holder; decisi…
-
FDA approval · 2025-12-09FDA Approved: IMITREX — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for IMITREX (sumatriptan) submitted by GlaxoSmithKline LLC.
-
FDA approval · 2025-12-09FDA Approved: SUMATRIPTAN — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for Sumatriptan submitted by Prasco Laboratories.
-
FDA approval · 2025-12-09FDA Approved: IMITREX — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for Imitrex (sumatriptan) submitted by GlaxoSmithKline LLC. This approval updates the product's …
-
CLINICAL_TRIALS withdrawal · 2025-12-08Clinical Trial Update: Single-Site Study of Naltrexone/Acetaminophen for the Acute Treatment of Migraine: A Phase 2 Randomized Trial [Phase 2]
The document notes that the Phase 2 randomized trial of naltrexone/acetaminophen for acute migraine treatment has been withdrawn.
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Efficacy of Xeomin for Migraines in Patients With Traumatic Brain Injuries vs. Anomalous Health Incidents
This clinical trial aims to evaluate the efficacy of Xeomin (incobotulinumtoxinA) for migraines in patients with traumatic brain injury, wit…
-
FDA approval · 2025-12-04FDA Approved: TOPIRAMATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved Glenmark Pharmaceuticals' supplemental application for Topiramate, enabling a generic version of this anticonvulsant. The a…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache [Phase 4]
Phase 4 trial of Eptinezumab in participants with migraine and medication overuse headache has completed and results have been posted.